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licenseKisspeptin system in female reproduction: A next-generation target
in the manipulation of sex hormonesThe discovery of the neuropeptide kisspeptin, originally
derived from its antimetastatic property affecting malignant
melanoma cells, as well as its role in reproductive function,
was a milestone in the field of reproductive biology.1,2 Con-
ventionally, the capacity for reproductive activity in mammals
involves coordinated communication between the hypothal-
amus, the anterior pituitary, and the gonads [the hypothal-
amicepituitaryegonadal (HPG) axis]. This includes
hypothalamic neuropeptides [gonadotropin-releasing hormone
(GnRH), synthesized in GnRH neurons scattered throughout
the preoptic area, as well as the organum vasculosum laminae
terminalis, and releasing into the portal circulation in a pul-
satile manner], gonadotropins [luteinizing hormone (LH) and
follicle-stimulating hormone (FSH) secreted by pituitary
gonadotroph cells], and sex steroid hormones (androgen
secreted by theca cells, as well as estrogen secreted by gran-
ulosa cells and progesterone secreted by luteinizing theca and
granulosa cells) secreted by the ovaries.1 However, there have
been significant advances in our understanding of the hier-
archical pathways that control GnRH release, where it has
been particularly noted that peptides and signaling pathways
regulate GnRH neuronal activity. Evidence now indicates that
kisspeptins, encoded by the KISS1 gene and secreted by
kisspeptin neurons, are critical regulators of sexual differ-
entiation and maturation, as well as normal adult reproduction
function in female mammals (menstrual cycles in women and
estrous cycles in rodents).3,4 Kisspeptin neurons are localized
in the arcuate nucleus and the rostral periventricular nucleus of
the third ventricle or the preoptic area. The latter releases
kisspeptin to gonadotrophs (GnRH neurons) and is mediated
by kisspeptin receptors (Kiss1r) that are highly expressed in
GnRH neurons and in other areas of the brain, as well as in
most endocrine tissues, including the pituitary gland, ovary,
and placenta.5
The study by Luo et al6 in this issue of the Journal of the
Chinese Medical Association entitled, “Expression of kiss-
peptin/kiss1r system in developing hypothalamus of female rat
and the possible effects on reproduction development and
maintenance” evaluated correlations between activity and/or
expression of the kisspeptin/kiss1r system in the hypothalamus
of rats and development of rats from Day 7 of infancy to Dayx.doi.org/10.1016/j.jcma.2016.02.003
901/Copyright © 2016, the Chinese Medical Association. Published by El
(http://creativecommons.org/licenses/by-nc-nd/4.0/).63 of adult stage. The authors found that the coexpression
pattern of the kisspeptin/kiss1r system and GnRH I in the
ventromedial nucleus of the hypothalamus and around the
ventral surface of the third ventricle in rats was time
dependent, revealing the lowest expression levels occurring
during the infant stage and higher expression levels during the
adult age. Based on the obvious and significant time-
dependent and progressive increase in coexpression of both
the kisspeptin/kiss1r system and GnRH I, the authors con-
cluded that the kisspeptin/kiss1r system may be mediated
through GnRH neurons to activate and maintain reproductive
function.6 As a result,6 this current issue reconfirmed the
critical role of kisspeptin/kiss1r in the reproductive system.
However, Luo et al's6 paper did not provide additional infor-
mation regarding the relationship between the initiation of
ovulation cycles (or aging processes of the ovary) and activity
of the kisspeptin/kiss1r system. Additionally, the authors also
failed to discuss the expression patterns of kisspeptin neurons
located in different areas, given that the two populations of
kisspeptin neurons respond differently to estradiol feedback
from the ovary through sexual dimorphism.4 It was reported
that kisspeptin neurons in the rostral periventricular nucleus of
the third ventricle presented a marked sexual dimorphism,
with more kisspeptin neurons in females compared to males,
and represented the main drivers of preovulatory GnRH/LH
surge.4 By contrast, kisspeptin neurons in the arcuate nucleus
are not sexually dimorphic.4 Furthermore, GnRH neurons do
not express estrogen receptor a, which is a primary estrogen
target,7,8 suggesting that estrogen acts as a regulator of GnRH
secretion through an indirect mechanism. In fact, estrogen
feedback to GnRH neurons is mediated by kisspeptin neurons,
which display estrogen-dependent changes in kisspeptin
expression.4 Therefore, it is well known that the use of GnRH
analogues to control HPG functions via stimulatory or inhib-
itory mechanisms of action9,10 might also be reproducible by
kisspeptin analogues, suggesting that Kiss1r agonists and
antagonists might provide another option to control HPG
functions.11 Additionally, the kisspeptin/neurokinin B/dynor-
phin system in the arcuate nucleus has provided important
clues to the neural mechanisms of GnRH pulse-generation
systems.12sevier Taiwan LLC. This is an open access article under the CC BY-NC-ND
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available knowledge of both agonist and antagonist. Kiss-
peptin agonists more profoundly suppressed testosterone lev-
els in rats and monkeys relative to natural kisspeptin, and
Phase I clinical studies showed that subcutaneous infusion of
kisspeptin analogues for 2 weeks in healthy male volunteers
rapidly, but reversibly, reduced testosterone levels in a dose-
dependent manner.13 This effect might vary dramatically in
normal healthy women, because twice-daily subcutaneous
injection of kisspeptin analogues does not abolish menstrual
cyclicity in healthy female volunteers.14 This emerging new
information suggested that additional physiological and
pharmacological studies are necessary to deepen our under-
standing of the kisspeptin/kiss1r system to eventually provide
novel therapeutic approaches similar to GnRH analogues, as
we have previously reported.15
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